McCarthy S, Wilton L, Murray M, et al (2012). The epidemiology of pharmacological treatments for attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...

Adults with attention-deficit/hyperactivity disorder (ADHD) are more frequently presenting for diagnosis and treatment. Medication is considered to be appropriate ...

A person with attention deficit hyperactivity disorder (ADHD) lacks the ability to pay attention, stay focussed, is overly active and may act impulsively. It is common to think ADHD affects mostly ...

Dialectical behavior therapy (DBT) is a form of cognitive-behavioral therapy originally designed for patients with borderline ...

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition ... Overall prognosis may depend on the severity and management of any comorbid disorders. Treatment for ADHD may be ...

In May 2024, Knight entered into an agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Ironshore Therapeutics, Inc. (now part of Collegium Pharmaceutical, Inc.; ...